Current Perspectives on Pyrroloiminoquinones: Distribution, Biosynthesis and Drug Discovery Potential
Pyrroloiminoquinones are a group of cytotoxic alkaloids most commonly isolated from marine sponges. Structurally, they are based on a tricyclic pyrrolo[4,3,2-de]quinoline core and encompass marine natural products such as makaluvamines, tsitsikammamines and discorhabdins. These diverse compounds are known to exhibit a broad spectrum of biological activities including anticancer, antiplasmodial, antimicrobial, antifungal and antiviral activities as well as the inhibition of several key cellular enzymes. The resurgence of interest in pyrroloiminoquinones and the convoluted understanding regarding their biological activities have prompted this review. Herein, we provided a concise summary of key findings and recent developments pertaining to their structural diversity, distribution, biogenesis, and their potential as chemical probes for drug development, including a discussion of promising synthetic analogs.
Top-30
Journals
|
1
2
|
|
|
Journal of Natural Products
2 publications, 12.5%
|
|
|
Marine Drugs
2 publications, 12.5%
|
|
|
Journal of the American Chemical Society
2 publications, 12.5%
|
|
|
Advanced Synthesis and Catalysis
1 publication, 6.25%
|
|
|
Angewandte Chemie - International Edition
1 publication, 6.25%
|
|
|
Angewandte Chemie
1 publication, 6.25%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 6.25%
|
|
|
Chemical Science
1 publication, 6.25%
|
|
|
mSphere
1 publication, 6.25%
|
|
|
Advances in Heterocyclic Chemistry
1 publication, 6.25%
|
|
|
Tetrahedron
1 publication, 6.25%
|
|
|
Chemical and Pharmaceutical Bulletin
1 publication, 6.25%
|
|
|
1
2
|
Publishers
|
1
2
3
4
|
|
|
American Chemical Society (ACS)
4 publications, 25%
|
|
|
Wiley
3 publications, 18.75%
|
|
|
Elsevier
3 publications, 18.75%
|
|
|
MDPI
2 publications, 12.5%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 6.25%
|
|
|
American Society for Microbiology
1 publication, 6.25%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 6.25%
|
|
|
Pharmaceutical Society of Japan
1 publication, 6.25%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.